Literature DB >> 18606894

Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab.

Antonio M Risitano, Ludovica Marando, Elisa Seneca, Bruno Rotoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18606894     DOI： 10.1182/blood-2008-04-151613

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

1.  Paroxysmal nocturnal hemoglobinuria and eculizumab.

Authors:  Lucio Luzzatto; Antonio Maria Risitano; Rosario Notaro
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  Paroxysmal nocturnal hemoglobinuria turning Coombs-positive.

Authors:  Alexander Röth; Sven Peine; Ulrich Dührsen
Journal:  Int J Hematol       Date:  2010-02-09       Impact factor: 2.490

3.  Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena.

Authors:  Alexander Röth; Christina Hock; Anna Konik; Sandra Christoph; Ulrich Dührsen
Journal:  Int J Hematol       Date:  2011-05-25       Impact factor: 2.490

4.  Ex vivo expansion and long-term hematopoietic reconstitution ability of sorted CD34+CD59+ cells from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Juan Xiao; Bing Han; Yong-Ji Wu; Yu-ping Zhong; Wan-ling Sun
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

5.  Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization.

Authors:  Anita Hill; Russell P Rother; Louise Arnold; Richard Kelly; Matthew J Cullen; Stephen J Richards; Peter Hillmen
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

6.  Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab.

Authors:  Suresh K Krishnan; Anita Hill; Peter Hillmen; Louise M Arnold; Gemma L Brooksbank; Alex Wood; Andrew Scarsbrook; Mervyn H Davies; Richard J Kelly
Journal:  Int J Hematol       Date:  2013-10-25       Impact factor: 2.490

Review 7.  Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles J Parker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

8.  Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.

Authors:  Antonio M Risitano; Daniel Ricklin; Yijun Huang; Edimara S Reis; Hui Chen; Patrizia Ricci; Zhuoer Lin; Caterina Pascariello; Maddalena Raia; Michela Sica; Luigi Del Vecchio; Fabrizio Pane; Florea Lupu; Rosario Notaro; Ranillo R G Resuello; Robert A DeAngelis; John D Lambris
Journal:  Blood       Date:  2014-02-04       Impact factor: 22.113

9.  Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria.

Authors:  David J Araten; Anna Paola Iori; Karen Brown; Giovanni Fernando Torelli; Walter Barberi; Fiammetta Natalino; Maria Stefania De Propris; Corrado Girmenia; Filippo Maria Salvatori; Orly Zelig; Robin Foà; Lucio Luzzatto
Journal:  J Hematol Oncol       Date:  2014-03-27       Impact factor: 17.388

10.  Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going.

Authors:  Antonio M Risitano
Journal:  Transl Med UniSa       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.